Related Stories
Study of Anti-Cancer Mitochondrial Drug Shows Additional Clinical Promise
STONY BROOK, NY, June 9, 2022 – A study of the lead agent (CPI-613) in a class of anticancer drugs undergoing Food and Drug Administration (FDA) approved clinical trials reveals that CPI-613 is effective against most...
June 9, 2022
4 min read
Laboratory Investigating Infectious Agents Receives Grant to Support Pandemic Preparedness
Stony Brook’s LCM facility will use $3 million of NIH funding for equipment and structural upgrades STONY BROOK, NY, November 14, 2022 – The Laboratory for Comparative Medicine (LCM) at the Renaissance School of...
November 14, 2022
2 min read
Stony Brook Joins World’s Largest Autism Study
STONY BROOK, NY, September 28, 2022 – Autism affects millions of families nationwide. Over the past few years, the Covid-19 pandemic changed the lives and routines of most people, and the challenges of managing life...
September 27, 2022
3 min read
Subscribe to Newsletter
Get the latest word on Stony Brook news, discoveries and people.